164 related articles for article (PubMed ID: 34342680)
1. Prognostic factors in adult brainstem glioma: a tertiary care center analysis and review of the literature.
Leibetseder A; Leitner J; Mair MJ; Meckel S; Hainfellner JA; Aichholzer M; Widhalm G; Dieckmann K; Weis S; Furtner J; von Oertzen T; Preusser M; Pichler J; Berghoff AS
J Neurol; 2022 Mar; 269(3):1574-1590. PubMed ID: 34342680
[TBL] [Abstract][Full Text] [Related]
2. Brainstem gliomas in adults: prognostic factors and classification.
Guillamo JS; Monjour A; Taillandier L; Devaux B; Varlet P; Haie-Meder C; Defer GL; Maison P; Mazeron JJ; Cornu P; Delattre JY;
Brain; 2001 Dec; 124(Pt 12):2528-39. PubMed ID: 11701605
[TBL] [Abstract][Full Text] [Related]
3. Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI.
Fujii Y; Muragaki Y; Maruyama T; Nitta M; Saito T; Ikuta S; Iseki H; Hongo K; Kawamata T
J Neurosurg; 2018 Jul; 129(1):1-9. PubMed ID: 28885120
[TBL] [Abstract][Full Text] [Related]
4. Adult brainstem glioma: a multicentre retrospective analysis of 47 Italian patients.
Rigamonti A; Simonetti G; Silvani A; Rudà R; Franchino F; Villani V; Pace A; Merli R; Servida M; Picca A; Berzero G; Cerase A; Chiarotti I; Spena G; Salmaggi A;
Neurol Sci; 2021 May; 42(5):1879-1886. PubMed ID: 32954462
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
6. Clinical management and outcome of histologically verified adult brainstem gliomas in Switzerland: a retrospective analysis of 21 patients.
Hundsberger T; Tonder M; Hottinger A; Brügge D; Roelcke U; Putora PM; Stupp R; Weller M
J Neurooncol; 2014 Jun; 118(2):321-328. PubMed ID: 24736829
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
Dahlrot RH
Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in adult brainstem gliomas: a multicenter, retrospective analysis of 101 cases.
Kesari S; Kim RS; Markos V; Drappatz J; Wen PY; Pruitt AA
J Neurooncol; 2008 Jun; 88(2):175-83. PubMed ID: 18365144
[TBL] [Abstract][Full Text] [Related]
9. Voxel-based clustered imaging by multiparameter diffusion tensor images for glioma grading.
Inano R; Oishi N; Kunieda T; Arakawa Y; Yamao Y; Shibata S; Kikuchi T; Fukuyama H; Miyamoto S
Neuroimage Clin; 2014; 5():396-407. PubMed ID: 25180159
[TBL] [Abstract][Full Text] [Related]
10. 18F-fluoro-ethyl-tyrosine positron emission tomography for grading and estimation of prognosis in patients with intracranial gliomas.
Gempt J; Bette S; Ryang YM; Buchmann N; Peschke P; Pyka T; Wester HJ; Förster S; Meyer B; Ringel F
Eur J Radiol; 2015 May; 84(5):955-62. PubMed ID: 25748815
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors effective on survival of patients with glioblastoma: Anadolu Medical Center experience.
Guden M; Ayata HB; Ceylan C; Kilic A; Engin K
Indian J Cancer; 2016; 53(3):382-386. PubMed ID: 28244465
[TBL] [Abstract][Full Text] [Related]
12. Brainstem glioma: Prediction of histopathologic grade based on conventional MR imaging.
Moharamzad Y; Sanei Taheri M; Niaghi F; Shobeiri E
Neuroradiol J; 2018 Feb; 31(1):10-17. PubMed ID: 29148317
[TBL] [Abstract][Full Text] [Related]
13. Retrospective analysis of 104 histologically proven adult brainstem gliomas: clinical symptoms, therapeutic approaches and prognostic factors.
Reithmeier T; Kuzeawu A; Hentschel B; Loeffler M; Trippel M; Nikkhah G
BMC Cancer; 2014 Feb; 14():115. PubMed ID: 24555482
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and prognostic factors of adult brainstem gliomas: A retrospective analysis of histologically-proven 40 cases.
Li S; Zhao Y; Huang H
Medicine (Baltimore); 2024 May; 103(18):e37910. PubMed ID: 38701282
[TBL] [Abstract][Full Text] [Related]
15. Accelerated progression of IDH mutant glioma after first recurrence.
Miller JJ; Loebel F; Juratli TA; Tummala SS; Williams EA; Batchelor TT; Arrillaga-Romany I; Cahill DP
Neuro Oncol; 2019 May; 21(5):669-677. PubMed ID: 30668823
[TBL] [Abstract][Full Text] [Related]
16. Corpus callosum involvement and postoperative outcomes of patients with gliomas.
Chen KT; Wu TW; Chuang CC; Hsu YH; Hsu PW; Huang YC; Lin TK; Chang CN; Lee ST; Wu CT; Tseng CK; Wang CC; Pai PC; Wei KC; Chen PY
J Neurooncol; 2015 Sep; 124(2):207-14. PubMed ID: 26033546
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathological characteristics and prognosis of diffuse midline gliomas with histone H3K27M mutation: an analysis of 30 cases].
Li HN; Shan CG; Fan CZ; Cheng LN; Wu SG; Liu MT; Jiang GY; Li Z
Zhonghua Bing Li Xue Za Zhi; 2019 Mar; 48(3):192-198. PubMed ID: 30831644
[No Abstract] [Full Text] [Related]
18. Sequential Apparent Diffusion Coefficient for Assessment of Tumor Progression in Patients with Low-Grade Glioma.
Chen IE; Swinburne N; Tsankova NM; Hefti MM; Aggarwal A; Doshi AH; Hormigo A; Delman BN; Nael K
AJNR Am J Neuroradiol; 2018 Jun; 39(6):1039-1046. PubMed ID: 29674411
[TBL] [Abstract][Full Text] [Related]
19. Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-L-tyrosine PET in comparison to MRI.
Galldiks N; Rapp M; Stoffels G; Fink GR; Shah NJ; Coenen HH; Sabel M; Langen KJ
Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):22-33. PubMed ID: 23053325
[TBL] [Abstract][Full Text] [Related]
20. Insular glioma resection: assessment of patient morbidity, survival, and tumor progression.
Sanai N; Polley MY; Berger MS
J Neurosurg; 2010 Jan; 112(1):1-9. PubMed ID: 19612970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
